Table 2. Comparison of results for the association between IL-6R and abdominal aortic aneurysm from human genetic analysis and mouse experimental models.
Model | Inhibition of IL-6 signalling | Effect on AAA growth/survival | p-value of effect | Other cardiovascular markers (p<0.05) |
---|---|---|---|---|
Humans stratified for IL6R-Asp358Ala | Minor allele associated with dampening of classical signalling. Effects on trans-signalling not clear. | Non-significant change in AAA growth (0.06mm/year)* | 0.136 | Increased IL-6, sIL-6R, CXCL10, CXCL11, IL1α and CD6; Reduced MMP3, OPG, IGFBP1, TIMP4 |
Angiotensin II + anti-TGFβ mouse model |
Both classical and trans-signalling | No difference in survival | 1.000 | Increased IL-6; Reduced SAA, IL-2, IL-5, CXCL1 and SBP |
Only trans-signalling | Improved survival | 0.040 | Increased IL-5; Reduced TNFα |
|
Elastase + anti-TGFβ mouse model |
Both classical and trans-signalling | Decreased survival | 0.029 | Increased recruitment of CD3+ T cells |
Only trans-signalling | Improved survival | 0.024 | Increased collagen content of the arterial wall |
Effect indicated per copy of the IL6-R minor allele.